Anemia Distinct HLA Associations by Stroke Subtype in Children with Sickle Cell
暂无分享,去创建一个
[1] W. O'Fallon,et al. Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms. , 2002, Journal of vascular surgery.
[2] S. Ballas,et al. Molecular characteristics of pediatric patients with sickle cell anemia and stroke , 2001, American journal of hematology.
[3] J J Goedert,et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.
[4] N Risch,et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. , 2001, American journal of human genetics.
[5] G. Vercellotti,et al. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. , 2000, Blood.
[6] J. Elion,et al. Acute clinical events in 299 homozygous sickle cell patients living in France , 2000, European journal of haematology.
[7] W. Klitz,et al. Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. , 2000, Blood.
[8] Scott T. Miller,et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. , 1999, Pediatrics.
[9] E. Karita,et al. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. , 1999, AIDS research and human retroviruses.
[10] Scott T. Miller,et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. , 1998, Blood.
[11] M. Fukui,et al. Analysis of class II genes of human leukocyte antigen in patients with Moyamoya disease , 1997, Clinical Neurology and Neurosurgery.
[12] L. Walsh,et al. Ischemic strokes in children , 1997, Indian journal of pediatrics.
[13] Scott T. Miller,et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. , 1996, AJNR. American journal of neuroradiology.
[14] M. Carrington,et al. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. , 1995, American journal of human genetics.
[15] G. Serjeant. Natural history and determinants of clinical severity of sickle cell disease , 1995, Current opinion in hematology.
[16] Qingbo Xu,et al. Is atherosclerosis an immunologically mediated disease? , 1995, Immunology today.
[17] H. Erlich,et al. A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes. , 1994, Tissue antigens.
[18] G. Dahlén,et al. Importance of Lp(a) lipoprotein and HLA genotypes in atherosclerosis and diabetes , 1994, Clinical genetics.
[19] R J Adams,et al. Alpha thalassemia and stroke risk in sickle cell anemia , 1994, American journal of hematology.
[20] H. Erlich,et al. Efficient typing of the HLA-B locus using the PCR and immobilized oligonucleotide probes , 1994 .
[21] G. Dahlén,et al. Lp(a) LIPOPROTEIN AND HLA‐DR GENOTYPE IN EARLY CORONARY ARTERY DISEASE , 1993, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[22] K. Ohene‐Frempong. Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. , 1991, Seminars in hematology.
[23] J. Adams. Cerebral infarction—its pathogenesis and interpretation , 1989, The Journal of pathology.
[24] J. Mohr,et al. Brain infarction in sickle cell anemia: Magnetic resonance imaging correlates , 1988, Annals of neurology.
[25] J. Verter,et al. Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD). , 1987, Controlled clinical trials.
[26] T. Kinney,et al. Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with sickle cell disease. , 1985, Journal of chronic diseases.
[27] Robert R. Sokal,et al. The Principles and Practice of Statistics in Biological Research. , 1982 .
[28] W. Rosse,et al. The cooperative study of sickle cell disease: review of study design and objectives. , 1982, The American journal of pediatric hematology/oncology.
[29] C. Pegelow,et al. The natural history of stroke in sickle cell disease. , 1978, The American journal of medicine.
[30] Steven G.E. Marsh,et al. Nomenclature for factors of the HLA system , 1975 .
[31] D. Powars. Natural history of sickle cell disease--the first ten years. , 1975, Seminars in hematology.
[32] F. James Rohlf,et al. Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .